presentation1 for cadilla

Post on 08-Apr-2018

219 Views

Category:

Documents

0 Downloads

Preview:

Click to see full reader

TRANSCRIPT

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 1/33

CADILLA

THE WORLD OF INJECTABLE

PRODUCTS

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 2/33

Objectives

� The objectives of the study form the basis forwork & provide a yardstick for evaluation andfulfillment of the project. The major objectives of the study are:

� To analyze the market potential of the injectablerange in Chandigarh, Lucknow and Ajmer.

� To analyze the major market players and closecompetitors in injectable market.

� To identify the major customers of the Injectableproducts & that of CADILLA.

� To analyze the market share of the company

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 3/33

Hypothesis

� Hypothesis 1: CHANDIGARH, LUCKNOW andAJMER is having good potential for injectableproducts.

� Hypothesis 2: The doctors are purchasingInjectable range of products depending on PRICE.

� Hypothesis 3: Private hospitals are a majorcustomer for Injectable products of CADILLA.

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 4/33

Technique used

� Convenience Sampling technique to get a preliminary sense of how people feelabout the topic in question.

� ii) A sample was taken for the purpose of achieving the research objective.

�a) Sampling Unit: The Retailers at CHANDIGARH, AJMER and LUCKNOW aresurveyed for the study.

� b) Sample size: A sample of 50 Retailers at CHANDIGRAH, AJMER and LUCKNOWwere taken.

� c) Sampling Technique: The samples were selected through Random Sampling

Method.

� d) Research Instrument: A structured Questionnaire was used as an instrument. Itwas carefully developed & debugged before circulating into the field. There areboth closed end questions & open-end questions.

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 5/33

About CADILLA

� CADILLA is one of the fast growing names in qualityproducts established in 2007. It has acquired a greatsuccess in its previous endeavours & has won the lionsshare in Northern markets of India. They are now pursuing

their corporate mission of spreading business in other partsof the country. They have launched themselves initially inthe injectable market of Northern regions, as it is the mostpotential market of the country.

QUALITY & REASONABLE PRICE are the two essentialfactors to succeed in this era of cut-throat competition.They make every effort to see to it that their merchandiseshall be of a quality that will merit the confidence of ourcustomers.

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 6/33

What CADILLA constitues ?

� LAND & BUILDING:

� RAW MATERIALS / SUPPLIERS:

� TRANSPORT

� MAN POWER:

� MARKETING & SELLING ARRANGEMENTS:

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 7/33

What else CADILLA offers?

� 1) CADILLA Injectables ensure optimization of standard as perExport G. M. P. ( Good Manufacturing Practices).

� 2) CADILLA Provides Safety with affordable price along with 1st

Quality Ampoules & Vials USP Type - I.

� 3) Self Sealing (Automatic Air Sealing) Butyl / Latex Rubber Plugsqualify more than 10 - 15 pricks.

� 4) A. R. Grade Imported Raw Material, ensure 100% Drug assay to

IP /BP / USP Standards.

� 5) High precision test like H. P. L. C

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 8/33

Products offered

1) Inj. DEFINIT

2) Inj. GENTLE

3) Inj. DXM

4) Inj. A D LOC

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 9/33

Following injections are also available:

� 1) INJ. DEXTROSE 25%

25 ml Ampoule

A bundle of energy

� 2) ATROPINE SULPHATE

0.6 mg/ml 1ml ampoule / 10ml Vial.

Rope in the life with ASCENT BIOCAREs Atropine

� 3) INJ. SODIUM BICARBONATE

7.5 % - 10 ml Ampoules

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 10/33

Continued..

� 4) INJ. ADRENALINE BITRATRATE INJ.1ml AmpouleKeep the heart beating

� 5) INJ. AMINOPHYLLINE25 mg / ml 10 ml AmpoulesClear the airway with ASCENT BIOCAREsAminophylline

� 6) INJ. CYNOCOBALAMIN500mcg/ml 30 ml Vial

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 11/33

Interpretations

� COMPANIES SUPPLYING INJECTABLES

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 12/33

CLOSE COMPETITORS

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 13/33

CUSTOMERS OF INJECTABLES

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 14/33

HOSPITALS USING INJECTABLES

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 15/33

MARKET SHARE

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 16/33

FACTORS INFLUENCING DEMAND

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 17/33

MAJOR CUSTOMERS OF CADILLA

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 18/33

KEY FEATURES OF CADILLAS

INJECTABLES

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 19/33

Suggestions to improve CADILLA Sales

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 20/33

Analyzing Strengths and Weaknesses

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 21/33

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 22/33

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 23/33

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 24/33

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 25/33

MARKET PERFORMANCE OF CADILLA:

� CADILLA is enjoying the major share of injectable market inCHANDIGARH,AJMER and LUCKNOW.

� The injectable products of CADILLA with greater demand areOndansetron, Diclofenac Sodium , Ranitidine, Gentamicin Sulphate ,etc. The other products find a movement as being ordered along

with the key products.

� In these three places private hospitals are found to be the majorhospitals with maximum consumption of Injectable products.

� The major customers of injectables products are GeneralPractitioners, gynecologists & general surgeons. The customers of 

CADILLA are General Practitioners.� The customers purchase the products depending upon price &

quality. These are the same features that influence the demand of CADILLA products

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 26/33

STRATEGY EMPLOYED

· Doctors are frequently visited as per the tour programme prepared.

New customers are approached through a complete detailing of the company products & withpromotional aids like pamphlets, brochures and visual aids & also samples.

·

New and old users are presented with motivational gifts & attractive offers. There is a friendlyrelationship built with the customers.

·

Various schemes are launched seasonally to keep the flow of orders maintained at all seasons.

·

Price discounts are offered on bulk purchases, frequent users & timely payment, etc.

·

The middle men are motivated through price off offers, quantity off offers, gift etc. they are also givenfestive offers.

·Bonanza offers are offered to middle men on achievement of annual targets achieved.

·

The representatives are offered schemes like incentives on achievement of sales target.

·

The representatives are provided with training programmes to develop their knowledge & personality.

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 27/33

CONCLUSIONS

� 1) As observed from the injectable market share graph 72% of samplefeels the share of injectable range at three cities BELOW 50%. Themaximum share is of tablet & capsules. This contradicts our HYPOTHESIS -1, that malegaon is having good potential for injectable products.

2) In case of injectables PRICE plays an important role for retention & toconvince the customers. As injectable is directly administered in to theblood, QUALITY is another major factor. Thus,this proves our HYPOTHESIS -2 that doctors purchase injectables depending on PRICE.

� 3) CADILLA products provides service to many hospitals in three cities. Butas observed, Government hospitals has the greatest demand for CADILLAproducts. This proves our HYPOTHESIS -3 that Government hospitals are amajor customer of CADILLA products .

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 28/33

CONTINUE

� 4) CADILLA products suffers from the problem of notmeeting the demand on time .AS suggested by majority of retailers, the organization can improve its sales volume if itmaintains a regular supply of products to meet the

demands.�

� 5) The sales promotion practiced & special benefitsprovided to the retailers at Government hospitals & by thecompetitors are the same.

� 6) The major sales volume of CADILLA depends upon onlyon a small range of its products. Thus, many products havereached decline or non-moving stage.

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 29/33

RECOMMENDATIONS

� 1) It may be useful to prepare a long term plan &follow it up.

� 2) Explore new product lines. R& D efforts have to

be specially streamlined for it. It must also go formanufacture of tablets, capsules & syrups tooutstand all close competitors.

� 3) To meet demand a proper production plan

must be formulated. The yearly requirementsmust be listed and accordingly productionsynchronized.

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 30/33

SOME MORE

� 4) CADILLA can practice many new schemes to

motivate customers & channel members.

5) The price structure must be revised toattract more prospects.

� 6) And as suggested by retailers regular supply

must be maintained.

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 31/33

QUESTIONAIRE

� 1. Name of the party:

� 2. Name of the retailer:

� 3. Address of the party:

� 4. Experience in the business:

� 5. Range of expertise:

� 6. Do you sell injectable range of products?

� 7. Which companys injectable range you sell?

� 8. Who are the major customers of the injectable range?

� 9. Which are the major hospitals that you serve?

� 10. Which doctors prescribe injectable products?

�11. According to you which molecule is moving faster in the market?

� 12. Which company enjoys the major share in injectables?

� 13. Market share of the injectable products in your territory:

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 32/33

SOME MORE

� 14. What are the factors that influence the demand of the product?

� 15. Do you use injectable range of products manufactured byCADILLA ?

� 16. Which molecule of CADILLA is in greater demand?

17. Who are the major customers of CADILLA products?� 18. Which Hospital has greater demand of CADILLA products?

� 19. What are the features of CADILLA products that encourage its

� demand?

� 20. What are the benefits provided by other companies?

21. Any suggestions to increase the sale volume of CADILLAproducts?

8/7/2019 Presentation1 FOR CADILLA

http://slidepdf.com/reader/full/presentation1-for-cadilla 33/33

THANK YOU

top related